2001

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that its Board of Directors has nominated Nancy-Ann DeParle to...

Company Satisfies European Post-Marketing Requirements for its GALILEO System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study1 show that among patients experiencing neurological complications after coronary artery bypass surgery, those who...

Company Announces Worldwide Approval of POWERSAIL and HIGHSAIL Coronary Dilatation Catheters Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in...

Patients With Implanted Devices Not Affected by this Action Indianapolis, IN and Menlo Park, CA - Guidant Corporation (NYSE and PCX: GDT) today announced it has voluntarily halted production and...

All Are Invited to Access the Guidant Briefing By Live Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a general...

Company First to File for Approval of Cardiac Resynchronization Therapy Defibrillator for Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX:GDT), a...

Company Receives CE Mark Approval on Latest Coronary Stent System and Filed for U.S. Approval Earlier This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...

Company Also Increases Direct Sales Organization to Support New Product Introductions Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Human Evaluation Expected to Begin in the Second Quarter of This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Top